<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784243/" ref="ordinalpos=1826&amp;ncbi_uid=5334991&amp;link_uid=PMC3784243" image-link="/pmc/articles/PMC3784243/figure/F1/" class="imagepopup">Figure 1. Effect of PD-1 <span class="highlight" style="background-color:">signaling</span> in T cells.  From: Role of the PD-1 <span class="highlight" style="background-color:">Pathway</span> in the Immune Response. </a></div><br /><div class="p4l_captionBody">PD-1 signaling dephosphorylates proximal signaling molecules and augments PTEN expression, inhibiting PI3K and AKT activation. The consequences include decreased T cell proliferation, cytokine production and cell survival. PD-1 inhibition can be overcome by strong TCR signaling, CD28 signaling or IL-2 signaling (not shown). SHP2, protein tyrosine phosphatase; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homolog; AKT, serine/threonine protein kinase; PIP3, Phosphatidylinositol (3,4,5)-triphosphate.</div></div>